Rybelsus vs Saxenda: Full Comparison (2026)

How does Rybelsus (Semaglutide (oral)) compare to Saxenda (Liraglutide)? We break down the weight loss data, pricing, side effects, and who each medication is best suited for.

Quick Answer

Rybelsus (Semaglutide (oral)) and Saxenda (Liraglutide) both work as GLP-1 receptor agonists but differ in formulation and dosing. Rybelsus is FDA-approved for type 2 diabetes, while Saxenda is approved for chronic weight management. Average weight loss: 5-10% of body weight (Rybelsus) vs 5-8% of body weight (Saxenda).

Side-by-Side Comparison

FeatureRybelsusSaxenda
Active IngredientSemaglutide (oral)Liraglutide
MechanismGLP-1 receptor agonistGLP-1 receptor agonist
FDA Approved ForType 2 diabetesChronic weight management
Doses3mg, 7mg, 14mg (daily oral tablet)0.6mg to 3mg (daily injection)
AdministrationDaily oral tablet on empty stomachDaily subcutaneous injection
Avg. Weight Loss5-10% of body weight5-8% of body weight
Monthly Price$936$1,350
Oral AvailableYesNo
Year Approved20192014

Prices reflect typical self-pay costs without insurance. Actual costs vary by pharmacy, location, and insurance plan. Last updated March 2026.

Which Produces More Weight Loss?

Both Rybelsus and Saxenda show similar average weight loss results (5-10% of body weight vs 5-8% of body weight). Individual results will vary depending on dosing, diet, exercise, and other factors.

Rybelsus
5-10% of body weight
average body weight loss

First oral GLP-1 medication. Lower doses than injectable semaglutide, resulting in less weight loss. Convenient for patients who prefer pills over injections.

Saxenda
5-8% of body weight
average body weight loss

One of the first FDA-approved GLP-1 medications for weight loss. Requires daily injections (vs weekly for newer options). Generally being replaced by more effective newer medications.

Which Costs Less?

At list price, Rybelsus is the more affordable option at $936/month compared to $1,350/month for Saxenda. However, actual out-of-pocket costs depend heavily on your insurance plan. Rybelsus with insurance: $10-$150/month typical copay. Saxenda with insurance: Varies widely.

Rybelsus
$936/month
With insurance: $10-$150/month typical copay

Manufacturer savings programs available

Saxenda
$1,350/month
With insurance: Varies widely

Manufacturer savings card available

Side Effects Comparison

Both Rybelsus (GLP-1 receptor agonist) and Saxenda (GLP-1 receptor agonist) share similar gastrointestinal side effects, which are the most commonly reported:

  • Nausea (most common for both medications)
  • Diarrhea and vomiting
  • Constipation
  • Abdominal pain
  • Decreased appetite
  • Headache, fatigue, dizziness (less common)

Serious but rare side effects for both include pancreatitis, gallbladder problems, and kidney issues. Both carry warnings about medullary thyroid carcinoma risk based on animal studies. Always discuss your full medical history with your doctor before starting either medication.

Which Should You Choose?

The best choice depends on your diagnosis, insurance coverage, weight loss goals, and personal preferences. Here is our general guidance:

Choose Rybelsus If
  • -You have type 2 diabetes (on-label use, better insurance coverage)
  • -You prefer an oral option over injections
  • -Cost is a concern ($936/month at list price)
  • -You prefer a daily dosing routine
Choose Saxenda If
  • -Your primary goal is weight loss (FDA-approved indication)
  • -You prefer a daily dosing routine
  • -Your doctor recommends Liraglutide based on your health profile

Find the Best GLP-1 Provider for You

Compare verified telehealth programs that prescribe Rybelsus, Saxenda, and other FDA-approved GLP-1 medications.

Frequently Asked Questions

Can I switch from Rybelsus to Saxenda?

Switching between Rybelsus and Saxenda is possible but requires medical supervision since they contain different active ingredients (Semaglutide (oral) vs Liraglutide). Your doctor will determine the appropriate starting dose and titration schedule for the new medication.

Which is better for weight loss: Rybelsus or Saxenda?

Both medications show similar average weight loss results. Rybelsus averages 5-10% of body weight and Saxenda averages 5-8% of body weight. Individual results depend on dosing, lifestyle, and other factors.

Is Rybelsus cheaper than Saxenda?

At list price, Rybelsus ($936/month) is less expensive than Saxenda ($1,350/month). With insurance, costs vary significantly. Rybelsus: $10-$150/month typical copay. Saxenda: Varies widely.

Do Rybelsus and Saxenda have the same side effects?

Both medications share similar gastrointestinal side effects (nausea, diarrhea, vomiting, constipation) as these are common to GLP-1 receptor agonists. However, since they contain different active ingredients, there may be differences in frequency and severity. Discuss your medical history with your doctor to determine which has a better safety profile for you.

Does insurance cover Rybelsus and Saxenda?

Coverage varies by plan. Rybelsus is FDA-approved for type 2 diabetes — insurance coverage is typically better for on-label use. Saxenda is FDA-approved for chronic weight management. Check with your specific insurance plan and ask your doctor about prior authorization requirements.

Find Your GLP-1 Match — Free Quiz